Other OTC Pharmaceuticals - Sudan

  • Sudan
  • In 2024, the revenue generated in the Other OTC Pharmaceuticals market in Sudan amounted to US$6.01m.
  • It is projected to experience an annual growth rate of 0.17% (CAGR 2024-2029).
  • Comparatively, the in the United States generates the highest revenue globally, with an estimated amount of US$7,171.00m in 2024.
  • When considering the population figures, the per person revenue in Sudan for 2024 is US$0.12.
  • Sudan's Other OTC Pharmaceuticals market is witnessing a growing demand for traditional herbal remedies and natural medicine.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Sudan has been experiencing steady growth in recent years.

Customer preferences:
In Sudan, customers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, the convenience of being able to purchase medications without a prescription has become increasingly appealing to consumers. Additionally, the affordability of OTC medications compared to prescription drugs has made them more accessible to a wider range of people.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Sudan is the increasing demand for products that address common health issues. This includes medications for pain relief, cough and cold, digestive problems, and allergies. As the population becomes more aware of these health issues and seeks immediate relief, the demand for OTC pharmaceuticals continues to rise. Another trend in the market is the growing popularity of herbal and natural remedies. Sudan has a rich tradition of using herbal medicines for various ailments, and this cultural preference is reflected in the market. Consumers are increasingly seeking out OTC products that are derived from natural sources and have fewer side effects. This trend is also driven by the global shift towards more sustainable and environmentally friendly products.

Local special circumstances:
Sudan's healthcare system faces several challenges, including limited access to healthcare facilities and a shortage of healthcare professionals. As a result, many individuals rely on self-medication and OTC pharmaceuticals to manage their health issues. This has contributed to the growth of the Other OTC Pharmaceuticals market in Sudan. Additionally, the ongoing political and economic instability in the country has led to a lack of availability of certain prescription medications. This has further fueled the demand for OTC alternatives.

Underlying macroeconomic factors:
Sudan's economy has been experiencing slow but steady growth in recent years. This has led to an increase in disposable income and improved living standards for many Sudanese citizens. As a result, more people are able to afford healthcare products, including OTC pharmaceuticals. Furthermore, the government has taken steps to improve the regulatory framework for OTC pharmaceuticals in Sudan. This has increased consumer confidence in the quality and safety of these products, further driving market growth. In conclusion, the Other OTC Pharmaceuticals market in Sudan is witnessing growth due to customer preferences for convenience and affordability, as well as the increasing demand for products that address common health issues. The market is also influenced by local special circumstances such as limited access to healthcare facilities and political instability. Underlying macroeconomic factors, including economic growth and improved regulatory framework, are also contributing to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)